Document:

Exhibit 10.15

 

Date: 19  April 2021

 

 

 

 

 

 

 

 

(1) KREOS CAPITAL VI (UK) LIMITED

 

(2) MDxHEALTH SA

 

 

 

 

 

 

 

 

	DEED OF AMENDMENT TO LOAN

FACILITY AGREEMENT

 

 

    1

     

    

 

THIS DEED is dated ____ April 2021 and
made between:

 

		(1)	KREOS CAPITAL VI (UK) LIMITED a company incorporated in England and Wales under registration number
11535385 whose registered office is at Amf Building, 25 Old Burlington Street, London W 1 S 3AN (the “Lender”); and

 

		(2)	MDxHEALTH SA, a limited liability company by shares, incorporated in Belgium and registered in
the Legal Entities Register (Liège) under number 0479.292.440 whose registered office is at Rue d’Abhooz 31, 4040 Herstal,
Belgium (the “Borrower”).

 

WHEREAS

 

		(A)	On 23 September 2019, the Lender and the Borrower entered into an agreement for a loan facility of up
to €9,000,000, as amended pursuant to a deed of amendment dated 19 October 2020 (the “Loan Agreement”).

 

		(B)	The Borrower has, as at the date of this Deed, drawn down the full amount of the loan facility made available
pursuant to the Loan Agreement (the “Drawdown Amount”).

 

		(C)	The Lender has now agreed to amend the repayment provisions of the Loan Agreement as detailed in the provisions
of this Deed.

 

NOW THIS DEED WITNESSETH as follows:

 

		1.	INTERPRETATION

 

		1.1	In this Deed, unless the context otherwise requires, the words and phrases that are defined in the Loan
Agreement (as further amended by this Deed) will bear the same meanings in this Deed.

 

		1.2	The headings in this Deed are inserted for convenience only and do not form part of this Deed and do not
affect its interpretation.

 

		2.	AMENDMENTS TO THE LOAN AGREEMENT

 

		2.1	The provisions of the Loan Agreement are hereby amended, with effect from the CP Satisfaction Date (as
defined below), to provide that:

 

		2.1.1	the Repayment Schedule for the Drawdown Amount shall be as set out in the Schedule to this Deed (the “New
Repayment Schedule”), which shall supersede and replace the Repayment Schedule issued by the Lender prior to the date of this
Deed. The Borrower acknowledges and agrees that in calculating and agreeing to the amounts and to the Monthly Repayment Dates in the New
Repayment Schedule, the Lender has taken into account all principal, interest, fees received by it and the Advance Payment deducted by
it prior to the date of this Deed and therefore, notwithstanding any provision of the Loan Agreement (including, but not limited to, the
Applicable Interest Rate) the amounts in the New Repayment Schedule are the remaining cash payments which still need to be paid by the
Borrower to the Lender;

 

		2.1.2	the monthly payments in the New Repayment Schedule comprising interest only will be considered to be the
“Interest Only Period”; and

 

		2.1.3	Clause 5.1.2 of the Loan Agreement is replaced as follows:

 

“In the event that the Borrower
shall have received gross proceeds for a minimum amount of USD 30,000,000 by way of new Equity Financing occurring before the end of the
Loan Term (and provided satisfactory evidence thereof to the Lender):

 

(i) the Interest Only Period shall
be extended with six Monthly Repayment Dates; or

 

    2

     

    

 

(ii) a new Interest Only Period of
sixth Monthly Repayment Dates shall start,

 

(without, for the avoidance of doubt,
extending the Loan Term and provided that if there are less than six Monthly Repayment Dates remaining until the end of the Loan Term
at the relevant time, the extended or new Interest Only Period will end on (and not include) the final Monthly Repayment Date) and the
Lender shall issue to the Borrower a new Repayment Schedule to replace the Repayment Schedule applicable at the time of such extension
or new Interest Only Period (provided that all monthly repayments after the extended or new Interest Only Period shall be equal instalments
of principal and interest).”

 

		2.2	In the event that the Lender converts the First Discretionary Convertible Loan and/or the Second Discretionary
Convertible (each as defined and in accordance with the Amended and Restated Convertible Loans Agreement (as defined below)) into shares
to be issued by the Borrower to the Lender, at the time of the conversion the Lender shall issue to the Borrower a further Repayment Schedule
to replace the New Repayment Schedule, reflecting, as a result of the conversion, the proportionate reduction in payments of principal
and interest to be made by the Borrower to the Lender over the remainder of the Loan Term and:

 

		2.2.1	as concerns the First Discretionary Convertible Loan, the €11,700 reduction in the End of Loan Payment;
and

 

		2.2.2	as concerns the Second Discretionary Convertible Loan, the €13,162.5 reduction in the End of Loan
Payment.

 

		2.3	The rescheduling and the amendment to the Loan Agreement provided for by this Deed is subject to the prior
satisfaction by the Borrower of the following conditions (with the date that these conditions are satisfied being the “CP Satisfaction
Date”):

 

		2.3.1	the delivery to the Lender of a copy of the resolutions of the Borrower’s board of directors authorising
the transactions contemplated by this Deed and the amended and restated convertible loans agreement originally dated 23 September 2019
in the form attached at Schedule 2 (the “Amended and Restated Convertible Loans Agreement”) and the execution and delivery
to the Lender of this Deed and associated documents;

 

		2.3.2	the Borrower having executed and delivered to the Lender (in accordance with clause 6.2 of this Deed)
this Deed, the Amended and Restated Convertible Loans Agreement and any amendments to and/or confirmations relating to the Security Documents;
and

 

		2.3.3	compliance by the Borrower of its obligations in Clauses 3 and 4 of this Deed.

 

		2.4	As from the CP Satisfaction Date, details of the End of Loan Payments under the heading Loan Facility
Terms in the Loan Agreement shall be deleted and replaced with:

 

“In relation to each Tranche,
6.50% of the amount drawn down under the relevant Tranche.”.

 

		2.5	As from the CP Satisfaction Date, the Convertible Loans Agreement shall be replaced by, and restated in
the form of, the Amended and Restated Convertible Loans Agreement as set out in Schedule 2.

 

		2.6	Save as hereby amended, all the provisions of the Loan Agreement will remain in full force and effect.

 

		2.7	In the event of any conflict between the terms of the Loan Agreement (as amended by this Deed) and the
New Repayment Schedule, the New Repayment Schedule shall prevail.

 

    3

     

    

 

		3.	REPRESENTATIONS AND WARRANTIES

 

		3.1	The Borrower hereby represents and warrants to the Lender that as at the date of this Deed and the CP
Satisfaction Date:

 

		3.1.1	this Deed and the Amended and Restated Convertible Loans Agreement, do now or, as the case may be, will,
upon execution and delivery, constitute the Borrower’s legal, valid and binding obligations enforceable against it in accordance
with their respective terms;

 

		3.1.2	the execution by the Borrower of this Deed will not involve or lead to a contravention in any material
respect of:

 

		(a)	any applicable law or other legal requirement;

 

		(b)	the constitutional documents of the Borrower or any Group Company; or

 

		(c)	any contractual or other obligation or restriction which is binding on the Borrower or any Group Company
or any of their assets;

 

		3.1.3	all material consents, licences, approvals and authorisations required by the Borrower in connection with
the entry into, performance, validity and enforceability of this Deed and the Amended and Restated Convertible Loans Agreement have been
or (upon execution thereof) shall have been obtained and shall be (or upon execution thereof shall be) in full force and effect during
the term of the Loan Agreement;

 

		3.1.4	the Borrower has the corporate capacity and has taken all corporate action necessary for it to execute
this Deed; and

 

		3.1.5	all representations and warranties provided by the Borrower in the Loan Agreement continue to be true
and correct in all material respects; and

 

		3.1.6	no Event of Default has occurred.

 

		3.2	The Borrower acknowledges that the Lender is entering into this Deed in reliance on the representations
and warranties contained in this Clause.

 

		4.	COSTS AND EXPENSES

 

The Borrower shall reimburse the Lender
for all of its costs reasonably incurred in relation to the negotiation, preparation, execution, performance and implementation of this
Deed and associated documents and the Amended and Restated Convertible Loans Agreement (subject to any agreed cap).

 

		5.	CONTINUING STATUS OF SECURITY

 

		5.1	The Borrower acknowledges and agrees that the Pledge Agreement:

 

		5.1.1	ranks as continuing security for the payment and discharge of all amounts due and payable by and obligations
of the Borrower under the Loan Documents; and

 

		5.1.2	shall continue in full force and effect in all respects.

 

    4

     

    

 

		6.	COUNTERPARTS

 

		6.1	This Deed may be executed in any number of counterparts, each of which when executed and delivered shall
constitute a duplicate original, but all the counterparts shall together constitute the one agreement.

 

		6.2	Transmission of the executed signature page of a counterpart of this Deed by e-mail (in PDF, JPEG or other
agreed format) shall take effect as delivery of an executed counterpart of this Deed. If this method of delivery is adopted, without prejudice
to the validity of the agreement thus made, each party to this Deed shall provide the other with the original of such counterpart as soon
as reasonably possible thereafter.

 

		6.3	No counterpart shall be effective until all parties to this Deed have executed and delivered at least
one counterpart.

 

		7.	MISCELLANEOUS

 

		7.1	A person who is not a party to this Deed may not enforce any of its terms under the Contracts (Rights
of Third Parties) Act 1999.

 

		7.2	If there is any conflict between the terms of this Deed and the Loan Agreement, the terms of this Deed
shall prevail.

 

		8.	GOVERNING LAW AND JURISDICTION

 

		8.1	This Deed and any dispute or claim arising out of or in connection with it or its subject matter or formation
(including non-contractual disputes or claims) shall be governed by and construed in accordance with the laws of England and Wales.

 

		8.2	The parties to this Deed irrevocably agree that the courts of England and Wales shall have exclusive jurisdiction
to settle any dispute or claim that arises out of, or in connection with, this Deed or its subject matter or formation (including non-contractual
disputes or claims).

 

    5

     

    

 

IN WITNESS WHEREOF, this Deed is executed
and delivered as a deed and takes effect on the date first written above.

 

EXECUTION PAGE

 

The Lender:

 

	EXECUTED and DELIVERED as a DEED on	)	 
	behalf of KREOS CAPITAL VI (UK)	)	/s/ Ross Ahlgren
	LIMITED acting by:	)	(signature of director)
		)	 
	Ross Ahlgren	)	 
	(print name of director) in the presence of:	)	 
	 	)	 

 

	Signature of witness:	/s/ Lauren Mahoney	 
	 	 	 
	Name of witness:	Lauren Mahoney	 
	 	 	 
	Address of witness:	Kreos Capital, AMF Building, 25-28

Old Burlington Street, London,

W1S 3AN, UK	 
	 	 	 
	Occupation of witness:	Portfolio Administrator	 

 

The Borrower:

 

	EXECUTED and DELIVERED as a DEED on	)	 
	behalf of MDxHEALTH SA, a company	)	 
	incorporated in Belgium, acting by:	)	/s/ Michael McGarrity
		)	(Authorised signatory Signature)
	Michael McGarrity	)	 
	(print name of director) in the presence of:	)	 
	 	)	 

 

    6

     

    

 

Schedule

 

New Repayment Schedule

 

	DUE DATE	DRAWDOWN

(€)	DEPOSIT (€)	
    FEES

    (€)
	CAPITAL

(€)	INTEREST

(€)	TOTAL PAYMENT

(€)
	 	 	 	 	 	 	 
	01-May-21	0.00	0.00	0.00	0.00	71,250.00	71,250.00
	01-Jun-21	0.00	0.00	0.00	0.00	71,250.00	71,250.00
	01-Jul-21	0.00	0.00	0.00	0.00	71,250.00	71,250.00
	01-Aug-21	0.00	0.00	0.00	0.00	71,250.00	71,250.00
	01-Sep-21	0.00	0.00	0.00	0.00	71,250.00	71,250.00
	01-Oct-21	0.00	0.00	0.00	0.00	71,250.00	71,250.00
	01-Nov-21	0.00	0.00	0.00	0.00	71,250.00	71,250.00
	01-Dec-21	0.00	0.00	0.00	0.00	71,250.00	71,250.00
	01-Jan-22	0.00	0.00	0.00	0.00	71,250.00	71,250.00
	01-Feb-22	0.00	0.00	0.00	463,206.35	0.00	463,206.35
	01-Mar-22	0.00	0.00	0.00	395,623.40	67,582.95	463,206.35
	01-Apr-22	0.00	0.00	0.00	398,755.42	64,450.93	463,206.35
	01-May-22	0.00	0.00	0.00	401,912.23	61,294.12	463,206.35
	01-Jun-22	0.00	0.00	0.00	405,094.04	58,112.31	463,206.35
	01-Jul-22	0.00	0.00	0.00	408,301.03	54,905.32	463,206.35
	01-Aug-22	0.00	0.00	0.00	411,533.42	51,672.93	463,206.35
	01-Sep-22	0.00	0.00	0.00	414,791.39	48,414.96	463,206.35
	01-Oct-22	0.00	0.00	0.00	418,075.15	45,131.20	463,206.35
	01-Nov-22	0.00	0.00	0.00	421,384.92	41,821.43	463,206.35
	01-Dec-22	0.00	0.00	0.00	424,720.88	38,485.47	463,206.35
	01-Jan-23	0.00	0.00	0.00	428,083.25	35,123.10	463,206.35
	01-Feb-23	0.00	0.00	0.00	431,472.25	31,734.10	463,206.35
	01-Mar-23	0.00	0.00	0.00	434,888.07	28,318.28	463,206.35
	01-Apr-23	0.00	0.00	0.00	438,330.93	24,875.42	463,206.35
	01-May-23	0.00	0.00	0.00	441,801.05	21,405.30	463,206.35
	01-Jun-23	0.00	0.00	0.00	445,298.64	17,907.71	463,206.35
	01-Jul-23	0.00	0.00	0.00	448,823.92	14,382.43	463,206.35
	01-Aug-23	0.00	0.00	0.00	452,377.11	10,829.24	463,206.35
	01-Sep-23	0.00	0.00	0.00	455,958.43	7,247.92	463,206.35
	01-Oct-23	0.00	(286,032.13)	585,000.00	459,568.10	3,638.25	762,174.22

(subject to the amount of any Discretionary Convertible Loan converting into shares of the Borrower in accordance with the Convertible Loans Agreement (as amended and restated on the date of this Deed)

 

    7

     

    

 

Schedule 2

 

Amended and Restated Convertible Loans Agreement

 

[Please see attached]

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

8Exhibit 10.16

 

Date:
19 April 2021

 

 

 

 

KREOS CAPITAL V I (UK) LIMITED

 

AND

 

MDXHEALTH SA

 

 

 

 

 

 

 

 

 

 

 

 

AMENDMENT AND RESTATEMENT AGREEMENT

RELATING TO A

CONVERTIBLE LOANS AGREEMENT

ORIGINALLY DATED 23 SEPTEMBER 2019, AS
AMENDED AND RESTATED ON 19

OCTOBER 2020

 

 

 

 

 

 

    

     

    

 

THIS DEED (this “Deed”)
is made on the date written above.

 

PARTIES:

 

	(1)	KREOS CAPITAL VI (UK) LIMITED a company incorporated in England and Wales under registration
number 11535385 whose registered office is at Amf Building, 25 Old Burlington Street, London W1S 3AN (the “Lender”);
and

 

	(2)	MDxHEALTH SA, a limited liability company by shares, incorporated in Belgium and registered in
the Legal Entities Register (Liège) under number 0479.292.440 whose registered office is at Rue d’Abhooz 31, 4040 Herstal,
Belgium (the “Borrower”).

 

BACKGROUND:

 

	(A)	The Lender and the Borrower entered into an agreement for the provisions of several convertible loans
originally dated 23 September 2019, as amended and restated on 19 October 2020 (the “Convertible Loans Agreement”).

 

	(B)	The Borrower and the Lender have agreed to amend and restate the Convertible Loans Agreement in the form
appended to this Deed.

 

IT IS AGREED as follows:

 

	1.	DEFINITIONS AND INTERPRETATION

 

	1.1	Terms defined in the Convertible Loans Agreement (as amended and restated by this Deed) shall have the
same respective meanings in this Deed unless the context otherwise requires.

 

	1.2	Unless the context otherwise requires, references in the Convertible Loans Agreement to “this Convertible
Loans Agreement” shall be to the Convertible Loans Agreement as amended and restated by this Deed and otherwise from time to time.

 

	1.3	Subject to the provisions of this Deed, the Convertible Loans Agreement shall remain in full force and
effect and shall be read and construed as one document with this Deed.

 

	2.	AMENDMENT AND RESTATEMENT OF THE CONVERTIBLE LOANS AGREEMENT

 

		With effect from the CP Satisfaction Date (as defined in the deed of amendment to the Loan Agreement
                                                                                to be entered into on the date of this Deed between the Borrower and the Lender), the Convertible Loans Agreement is hereby amended
                                                                                and restated so as to take effect as set out in the Appendix to this Deed.

 

    2

     

    

 

	3.	REPRESENTATIONS AND WARRANTIES

 

	3.1	The Borrower hereby represents and warrants to the Lender that:

 

		3.1.1	this Deed and the Convertible Loans Agreement constitute the Borrower’s legal, valid and binding
obligations enforceable against it in accordance with its respective terms;

 

		3.1.2	the execution by the Borrower of this Deed will not involve or lead to a contravention in any material
respect of:

 

		3.1.2.1	any applicable law or other legal requirement;

 

		3.1.2.2	the constitutional documents of the Borrower; or

 

		3.1.2.3	any contractual or other obligation or restriction which is binding on the Borrower or any Group Company
or any of their assets;

 

		3.1.3	all material consents, licences, approvals and authorisations required by the Borrower in connection with
the entry into, performance, validity and enforceability of this Deed have been or (upon execution thereof) shall have been obtained and
shall be (or upon execution thereof shall be) in full force and effect during the term of the Convertible Loans Agreement;

 

		3.1.4	the Borrower has the corporate capacity and has taken all corporate action necessary for it to execute
this Deed;

 

		3.1.5	all representations and warranties provided by the Borrower in the Loan Agreement that are capable of
repetition continue to be true and correct in all material respects; and

 

		3.1.6	no Event of Default has occurred.

 

	3.2	The Borrower acknowledges that the Lender is entering into this Deed in reliance on the representations
and warranties contained in this Clause.

 

	4.	CONTINUING STATUS OF SECURITY

 

	4.1	The Borrower confirms that the Security Documents:

 

		4.1.1	rank as continuing security for the payment and discharge of all amounts due and payable by and obligations
of the Borrower under the Loan Documents; and

 

		4.1.2	shall continue in full force and effect in all respects.

 

	5.	COSTS AND EXPENSES

 

		The Borrower shall reimburse the Lender for all of its costs reasonably incurred in relation to the
                                                                                negotiation, preparation, execution, performance and implementation of this Deed and associated documents, including but not limited
                                                                                to, any amendments to and/or confirmations relating to the Security Documents (subject to any agreed cap).

 

    3

     

    

 

	6.	COUNTERPARTS

 

	6.1	This Deed may be executed in any number of counterparts, each of which when executed and delivered shall
constitute a duplicate original, but all the counterparts shall together constitute the one agreement.

 

	6.2	Transmission of the executed signature page of a counterpart of this Deed by e-mail (in PDF, JPEG or other
agreed format) shall take effect as delivery of an executed counterpart of this Deed. If this method of delivery is adopted, without prejudice
to the validity of the agreement thus made, each party to this Deed shall provide the others with the original of such counterpart as
soon as reasonably possible thereafter.

 

	6.3	No counterpart shall be effective until all parties has executed and delivered at least one counterpart.

 

	7.	MISCELLANEOUS

 

	7.1	A person who is not a party to this Deed may not enforce any of its terms under the Contracts (Rights
of Third Parties) Act 1999.

 

	7.2	If there is any conflict between the terms of this Deed and the Convertible Loans Agreement, the terms
of this Deed shall prevail.

 

	8.	GOVERNING LAW AND JURISDICTION

 

	8.1	This Deed and any dispute or claim arising out of or in connection with it or its subject matter or formation
(including non-contractual disputes or claims) shall be governed by and construed in accordance with the laws of England and Wales.

 

	8.2	The parties to this Deed irrevocably agree that the courts of England and Wales shall have exclusive jurisdiction
to settle any dispute or claim that arises out of, or in connection with, this Deed or its subject matter or formation (including non-contractual
disputes or claims).

 

EXECUTED as a DEED and delivered
on the date stated at the beginning of this document.

 

    4

     

    

 

EXECUTION PAGE

 

The Lender:

 

	EXECUTED and DELIVERED as a	)	 
	DEED on behalf of KREOS CAPITAL VI	)	 
	(UK) LIMITED acting by:	)	 
	 	)	 
	 	)	 
	Ross Ahlgren	)	/s/ Ross Ahlgren
	(print name of director) in the presence of:	)	(signature of director)
	 	)	 
	 	)	 
	Signature of witness:	/s/ Lauren Mahoney	 	 
	 	 	 
	Name of witness: Lauren Mahoney	 	 
	 	 	 
	Address of witness: Kreos Capital, AMF Building, 25-28	 	 
	Old Burlington Street, London	 	 
	W1S 3AN, UK	 	 
	Occupation of	 	 
	Witness:	 	 
	Portfolio Administrator	 	 

 

    5

     

    

 

The Borrower:

 

	
    EXECUTED and DELIVERED
as a
	)	 
	DEED on behalf of MDx HEALTH SA, a	)	 
	company incorporated in Belgium, acting	)	 
	by:	)	 
	 	)	 
	Michael McGarrity	)	/s/ Michael McGarrity
	(Authorised signatory name)	)	(Authorised signatory signature)

 

    6

     

    

 

Schedule

Form of Am ended and Restated Convertible
Loans Agreement

 

 

 

[Please see attached]

 

 

7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00334-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00334-of-00352.parquet"}]]